Patent · US Active

Methods and reagents for identifying/isolating T regulatory (Treg) cells and for treating individuals

US8815526B2 · kind B2 · utility

3Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2006
Grant dateAug 26, 2014
Priority date
Expiry dateFeb 25, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/205
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An affinity ligand is reactive to the GARP protein may be capable of binding to an extracellular domain of GARP protein expressed on regulatory T (Treg) cells. The affinity ligand may be an antibody and may be used to identify Treg cells. A method comprises providing a blood sample from a subject and determining the amount of Treg cells in that sample. A composition containing Treg cells may be administered to an individual to suppress effector T cell activity in the individual. A composition containing an affinity ligand capable of binding to a GARP domain may be administered to an individual to suppress Treg cell activity and increase effector T cell activity in the individual. A kit for detecting Treg cells may include an affinity ligand reactive with mammalian GARP protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.